Looks like this event has already ended.

Check out upcoming events by this organizer, or organize your very own event.

View upcoming events Create an event

Gene Therapy for Inherited Metabolic Disease

Thursday, 8 March 2012 from 10:00 to 17:45 (GMT)

London, United Kingdom

Gene Therapy for Inherited Metabolic Disease

Ticket Information

Ticket Type Sales End Price Fee Quantity
BSGT member / UCL/ Genetics Society
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £70.00 £0.00
BSGT student member
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £50.00 £0.00
BSGT Non-members
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £100.00 £0.00
Student BSGT non-member
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £70.00 £0.00
Invited Speaker/ Chairperson
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £0.00 £0.00
Member of the Organising Committee
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £0.00 £0.00
Sponsor (one place per organisation)
Gene Therapy for Inherited Metabolic Disease BSGT Satellite Meeting, 8th March 2012, UCL Institute of Child Health, London
Ended £0.00 £0.00
SHARE THIS EVENT

Event Details

Gene therapy is now fulfilling its potential and has been successfully applied to a range of diseases.  Many inherited metabolic disorders represent suitable targets for this type of treatment.

The aim of this meeting is to establish and encourage a closer interface between clinicians and scientists with which to enhance research and deliver clinical gene therapy for inherited metabolic disorders to UK patients at the earliest opportunity.

This can be achieved by bringing together those who can design and deliver therapy to patients; by learning from those at the forefront of research and those with experience of clinical trials wherever they are in the world, and facilitating collaborative links; by learning how to assess what is best science, best clinical practice and identify patients who will most benefit.

To be inclusive for everyone, the meeting will comprise presentations explaining the basics of gene therapy, descriptions of the major metabolic diseases with unmet therapeutic needs, cutting edge current and planned clinical gene therapy trials and time for open discussion and networking.

This event is a satellite meeting of the main British Society of Gene Therapy conference which will be held at the same venue on 9th March 2012.  We encourage those interested in finding out more about stem cell and gene therapy on a wider scale to attend register at www.bsgt.org

Continuing Professional Development (CPD) points will be available for attendance at these events.

Confirmed Speakers:

Simon Waddington (UCL)

Charles P Venditti (NIH)

Ian Alexander (Sydney)

Ahad Rahim (UCL)

Manju Kurian (UCL)

Krystof Bankiewicz (UCSF)

Tim Cox (Cambridge University)

Nathalie Cartier (Inserm, Paris)

Brian Bigger (Manchester)

Dolan Sondhi (Cornell)

Mark Sands (Washington University in St. Louis)

Adrian Thrasher (UCL)

Alessandra Biffi (San Raffaele Institute, Milan)

Ashok Velodi (GOSH)

Peter Clayton (UCL)


We are also very pleased to acknolwedge the support of our sponsors.


We look forward to welcoming you soon.

Paul Gissen, Emma Footitt, Sara Mole and Steven Howe, local organising team.